ESVNF (Apptly Health Technologies) Research & Development: $ Mil (TTM As of Jan. 2026)


ESVNF Apptly Health Technologies Corp ESVNF
13 GF Score
Price $0.04
View Full Analysis

What is Apptly Health Technologies Research & Development?

Apptly Health Technologies ESVNF -82.23% 13 Research & Development is $ Mil as of Jan. 2026. GuruFocus rates ESVNF with a GF Score™ of 13/100.

Research & Development is the aggregate amount of research and development expenses during the year. Apptly Health Technologies's Research & Development for the three months ended in Jan. 2026 was $0.00 Mil. Apptly Health Technologies does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Jan. 2026.

Apptly Health Technologies  (OTCPK:ESVNF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Apptly Health Technologies Research & Development Related Terms

Apptly Health Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Apptly Health Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apptly Health Technologies Research & Development Chart

Apptly Health Technologies Annual Data
Trend Dec23
Research & Development
0.00

Apptly Health Technologies Quarterly Data
Dec23 Dec24 Jan26
Research & Development 0.00 0.00 0.00
ESVNF
13GF Score
Apptly Health Technologies Corp ESVNF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apptly Health Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $ Mil mean?
Apptly Health Technologies (ESVNF) has a Research & Development of $ Mil as of Jan. 2026. Research and development expense is the total cost for research and development activities. View historical data on Apptly Health Technologies and its competitors.
Is Apptly Health Technologies' Research & Development too high?
Apptly Health Technologies' current Research & Development is $ Mil. Overall, Apptly Health Technologies has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Apptly Health Technologies' Research & Development compare to VEEV and BTSG?
Apptly Health Technologies' Research & Development of $ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Apptly Health Technologies and its competitors. Apptly Health Technologies's current Research & Development is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apptly Health Technologies stock overvalued right now?
Apptly Health Technologies (ESVNF) has a current Research & Development of $ Mil. The current Research & Development is $ Mil. Apptly Health Technologies' overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Apptly Health Technologies (ESVNF), the current Research & Development is $ Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apptly Health Technologies Business Description

Other Exchanges 4KL0:GermanyAPPT:Canada
Address 918 - 1030 West Georgia Street, Vancouver, BC, CAN, V6E 2Y3
UBERDOC Health Technologies Corp is a healthcare-focused investment company. It operates a healthcare marketplace that connects patients directly with physicians and specialists across multiple medical fields in the U.S. It provides access to care without referral or insurance barriers. Its platform is designed to support patient access to healthcare and to assist physicians in managing their practices.
13GF Score

Get the complete analysis for ESVNF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.04
Price